Non-obese NAFLD patients have a higher G allele of rs738409 than obese NAFLD patients, and the identified risk allele is strongly associated with increased hepatic fat content, hepatic inflammation, and elevated ALT levels (59). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.